MFDS — authorised 23 February 2015
- Marketing authorisation holder: NOVARTIS PHARMS CORP
- Status: likely_approved
🇰🇷 Farydak in South Korea
MFDS authorised Farydak on 23 February 2015
Marketing authorisation
Farydak in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in South Korea
Frequently asked questions
Is Farydak approved in South Korea?
Yes. MFDS authorised it on 23 February 2015.
Who is the marketing authorisation holder for Farydak in South Korea?
NOVARTIS PHARMS CORP holds the South Korean marketing authorisation.